Salbutamol modifies the neuromuscular junction in a mouse model of ColQ myasthenic syndrome

Volume: 28, Issue: 14, Pages: 2339 - 2351
Published: Apr 1, 2019
Abstract
The β-adrenergic agonists salbutamol and ephedrine have proven to be effective as therapies for human disorders of the neuromuscular junction, in particular many subsets of congenital myasthenic syndromes. However, the mechanisms underlying this clinical benefit are unknown and improved understanding of the effect of adrenergic signalling on the neuromuscular junction is essential to facilitate the development of more targeted therapies. Here,...
Paper Details
Title
Salbutamol modifies the neuromuscular junction in a mouse model of ColQ myasthenic syndrome
Published Date
Apr 1, 2019
Volume
28
Issue
14
Pages
2339 - 2351
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.